✦ LIBER ✦

Clinical response and safety of LHRH agcnist treatment in prostatic carcinoma

✍ Scribed by N. Faure; A. Lemay; B. Laroche; G. Robert; M. Thabet; R. Roy; C. Jean; A.T.A. Fazekas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of LHRH agcnist trea

✍ A. Lemay; R. Maheux; N. Faure; C. Jean; A.T.A. Fazekas 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 90 KB

TREATMENT OF ADVANCED PROSTATIC CANCER W

✍ Ahmed, S.R.; Shalet, S.M.; Brooman, P.J.C.; Howell, A.; Blacklock, N.J.; Rickard 📂 Article 📅 1983 🏛 The Lancet 🌐 English ⚖ 924 KB

COMBINED TREATMENT WITH LHRH AGONIST AND

✍ Labrie, Fernand; Belanger, Alain; Dupont, Andre; Emond, Jean; Lacoursiere, Yves; 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 150 KB

LHRH Analogues as Primary Treatment for

✍ S. J. HAMPSON; J. H. DAVIES; C. R. CHAR1G; R. J. SHEARER 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Clinical study of LHRH (ICI 118.630-Zola

✍ Mauriac, L.; Coste, Ph.; Richaud, P.; Lamarche, Ph.; Mage, Ph.; Bonichon, F. 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 144 KB

The response of prostatic carcinoma to œ

✍ J. D. Fergusson; L. M. Franks 📂 Article 📅 1953 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB